FreshPoint Oklahoma City, LLC inspected by FDA in Oklahoma City on Dec. 11, 2024

Vid Desai FDA’s Chief Information Officer - Official Website
Vid Desai FDA’s Chief Information Officer - Official Website
0Comments

On December 11, 2024, the Food and Drug Administration conducted an inspection of FreshPoint Oklahoma City, LLC in Oklahoma City to assess foodborne biological hazards, according to data posted on the FDA’s website.

The FDA’s final report concluded that FreshPoint Oklahoma City, LLC did not need to implement any corrective measures regarding its management operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA - Official Website

641 Management, LLC in Oklahoma City scheduled for FDA inspection Nov. 13, 2024

641 Management, LLC in Oklahoma City underwent an FDA inspection on November 13, 2024, focusing on foodborne biological hazards, according to information available on the FDA’s website.

Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) - Official website

Cao Nguyen, Inc. inspected by FDA in Oklahoma City on Nov. 19, 2024

On November 19, 2024, the FDA conducted an inspection of Cao Nguyen, Inc. in Oklahoma City focusing on foodborne biological hazards, according to information available on the FDA’s website.

Senator James Lankford, US Senator for Oklahoma - Official U.S. Senate headshot

Oklahoma congressional delegation urges CMS approval for state’s Rural Health Transformation proposal

US Senators James Lankford and Markwayne Mullin, along with Representatives Tom Cole, Frank Lucas, Kevin Hern, Stephanie Bice, and Josh Brecheen—all from Oklahoma—have sent a letter to Centers for Medicare and Medicaid Services (CMS) Director…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from OKC Standard.